| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Epothilone B | GDSC1000 | pan-cancer | AAC | 0.084 | 0.02 |
| mRNA | navitoclax:piperlongumine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.082 | 0.02 |
| mRNA | YM-155 | CTRPv2 | pan-cancer | AAC | 0.088 | 0.02 |
| mRNA | BRD-K30019337 | CTRPv2 | pan-cancer | AAC | -0.16 | 0.02 |
| mRNA | GSK-650394 | GDSC1000 | pan-cancer | AAC | 0.084 | 0.02 |
| mRNA | BRD-K52037352 | CTRPv2 | pan-cancer | AAC | -0.092 | 0.02 |
| mRNA | Nutlin-3 | CTRPv2 | pan-cancer | AAC | -0.078 | 0.02 |
| mRNA | BI-2536 | CTRPv2 | pan-cancer | AAC | 0.071 | 0.02 |
| mRNA | BRD-K41334119 | CTRPv2 | pan-cancer | AAC | -0.17 | 0.03 |
| mRNA | Topotecan | CCLE | pan-cancer | AAC | 0.095 | 0.03 |